-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Gain Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q2 2021 to Q3 2024.
- Gain Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $358K, a 56.2% decline year-over-year.
- Gain Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $2.58M, a 20.9% decline year-over-year.
- Gain Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $3.26M, a 114% increase from 2022.
- Gain Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $1.53M, a 81.9% increase from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)